Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;6(2):117-22.

Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents

Affiliations

Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents

L Saghaie et al. Res Pharm Sci. 2011 Jul.

Abstract

A series of 3-hydroxypyridin-4-one derivatives (HPOs) were synthesized and their partition coefficient values (K(part)) were determined. The cytotoxic effects of these iron chelators against Hela cancer cells were also evaluated. The IC(50) of HPOs was determined using MTT assay. Among these ligands, compound 4e (K(part)=5.02) with an IC(50) of 30 μM and 4f (K(part)=0.1) with an IC(50) of 700 μM showed the lowest and highest IC(50)s, respectively. In conclusion, the introduction of a more hydrophobic functional group (such as butyl in compound 4e) on the nitrogen of pyridinone ring resulted in higher cytotoxic activity of ligands.

Keywords: 3-Hydroxypyridin-4-one derivatives; Cytotoxicity; Hela cells; Iron chelators; Partition coefficient.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of two iron (III) chelators
Fig. 2
Fig. 2
Synthesis scheme of 1-substituted-3-hydroxypyridin-4-ones derivatives

Similar articles

Cited by

References

    1. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford: University Press; 1999. pp. 48–73.
    1. Crichton RR. John Wiley & Sons. 2nd ed. England: Chichester; 2001. Inorganic biochemistry of iron metabolism; pp. 235–243.
    1. Brittenham GM. Disorders of iron metabolism: iron deficiency and iron overload. In: Hoffman R, Benz E, Shatill S, Furie B, Cohen H, editors. Hematology: basic principles and practice. New York: Churchill Livingstone; 2009. pp. 453–468.
    1. Hershko C, Konijin AM, Link G. Iron chelators for thalassaemia. Br J Hematol. 1998;101:399–406. - PubMed
    1. Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu ZD, Hider RC. Synthesis, physicochemical properties and evaluation of N-substituted-2 alkyl-3-hydroxy-4(1H)-pyridinones. J Med Chem. 1998;41:3347–3359. - PubMed

LinkOut - more resources